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The mechanism of intracellular retention for the large surface protein (L) of duck hepatitis B virus (DHBV) was analyzed
by examination of the transmembrane topologies and secretory properties of a collection of DHBV L mutants and compared
with that of human hepatitis B virus (HBV) L. Our results demonstrate that, in contrast to its HBV counterpart, intracellular
retention of DHBV L does not depend on the cytosolic disposition of its preS domain: L mutants with either cytosolic or
lumenal preS were mostly retained in the absence of the small surface protein (S), whereas coexpression with S resulted in
efficient secretion of both topological forms. Coexpression of the wild-type DHBV L with S resulted in efficient incorporation
of L into secreted S1L particles, whereas HBV L was partially excluded from secreted particles under the same conditions.
We propose that HBV provides L retention even in the presence of an excess of S, by exclusion of molecules with cytosolic
preS domains from secreted particles at the stage of their assembly. DHBV lacks such a retention mechanism due to the
absence of topological selection in particulate assembly. © 1998 Academic Press
INTRODUCTION
The virus family Hepadnaviridae comprises two gen-
era: orthohepadnaviruses and avihepadnaviruses. Hu-
man hepatitis B virus (HBV) and duck hepatitis B virus
(DHBV) are the prototype members of these genera (see
Ganem, 1996, for review). These two viruses exhibit a
number of differences, including those between the sur-
face proteins. HBV carries in its envelope three carboxy-
coterminal proteins referred to as small (S), middle (M),
and large (L) surface protein, while the DHBV envelope
contains only S and L proteins. S coincides with the
C-terminal portion of L (the S domain), with the N-termi-
nal extension of L (the preS domain) consisting of 163
amino acids (aa) (preS112, HBV subtype ayw) or 161 aa
(DHBV, strain 16).
Hepadnaviral surface proteins are synthesized on the
endoplasmic reticulum (ER) as transmembrane proteins
with S domains having multispanning topologies. The
preS2 extension of HBV M protein is translocated co-
translationally into the ER lumen. PreS domains of both
HBV and DHBV L initially remain in the cytosol and only
posttranslationally a fraction of polypeptides reorient
their preS domains into the lumen (Bruss et al., 1994; Guo
and Pugh, 1997; Ostapchuk et al., 1994; Prange and
Streeck, 1995). Guo and Pugh (1997) have also identified
a third form of DHBV L, intermediate between newly
synthesized and fully translocated. The N-terminus of L
is myristylated in both viruses (Macrae et al., 1991; Pers-
ing et al., 1987) and a proportion of DHBV L is phosphor-
ylated (Grgacic and Anderson, 1994). Surface proteins of
HBV are partially N-glycosylated, whereas DHBV pro-
teins are not (Pugh et al., 1987), though one potential
N-glycosylation site is present in the preS sequence and
another in S.
In infections, hepadnaviral surface proteins do not
only form the envelopes of virions, but also self-assem-
ble into lipoprotein subviral particles which are efficiently
secreted from cells. Subviral particles are produced in
large excess over virions. HBV generates two types of
subviral particles—spheres and filaments, both approx-
imately 20 nm in diameter, while subviral particles
formed by DHBV are pleomorphic spheres 40–60 nm in
diameter. L protein is very scarce in HBV spherical sub-
viral particles, whereas approximately 10- and 20-fold
more of it is incorporated in filaments and virions, re-
spectively (Heermann et al., 1984). In contrast, a compar-
ison of the L content between DHBV subviral particles
and virions does not reveal significant differences (Pugh
et al., 1987; Schlicht et al., 1987).
When expressed in cell culture in the absence of other
viral components, HBV S and M are secreted as 20-nm
spherical particles, whereas L is retained in a pre-Golgi
compartment and can trans-inhibit secretion of M and S
in a dose-dependent fashion (Cheng et al., 1986; Chisari
et al., 1986; Ou and Rutter, 1987; Persing et al., 1986;
Standring et al., 1986; Xu et al., 1997). HBV L retention is
1 To whom correspondence and reprint requests should be ad-
dressed. Fax: 61 3 9282 2100. E-mail: anderson@burnet.edu.au.
VIROLOGY 242, 266–278 (1998)
ARTICLE NO. VY979015
0042-6822/98 $25.00
Copyright © 1998 by Academic Press
All rights of reproduction in any form reserved.
266
strongly dependent on the presence of two unrelated
factors: the N-terminal myristic acid and the initially cy-
tosolic location of the preS domain, either of which is
sufficient to confer retention (Bruss and Vieluf, 1995;
Gallina et al., 1995; Gazina et al., 1996; Kuroki et al.,
1989). Gerhardt and Bruss (1995) have demonstrated that
DHBV L is also retained when expressed in COS-7 cells,
but its retention mechanism has not been studied.
In this work we examined transmembrane topologies
and secretory properties of a collection of DHBV L mu-
tants. Our results demonstrate that, in contrast to the
HBV homolog, intracellular retention of DHBV L does not
depend on preS topology, and DHBV L does not have a
mechanism sorting it from the bulk of exported surface
protein.
RESULTS
Cotranslational translocation of preS results in its
glycosylation, but not in L secretion
Cotranslational translocation of preS domains of HBV
surface proteins, indicated by N-glycosylation in these
domains (Bruss and Vieluf, 1995; Gallina et al., 1995;
Prange and Streeck, 1995), and absence of myristylation
are the major requirements for their secretion (Bruss and
Vieluf, 1995; Gallina et al., 1995). Therefore, we first
investigated whether it is the initially cytosolic disposi-
tion of preS and its myristylation which results in intra-
cellular retention of DHBV L. It has been suggested that
N-glycosylation in preS of DHBV L protein can serve as
an indicator of cotranslational translocation, as for HBV L
protein (Swameye and Schaller, 1997), and we therefore
examined the glycosylation and secretion properties of
mutant L proteins.
To provide cotranslational translocation of preS we
created a mutant in which the preprolactin signal se-
quence was fused N-terminally to Gly2 of L protein
(PPL-L, Fig. 1). Fusion of the preprolactin signal se-
quence also prevents myristylation of Gly2. Since two
potential N-glycosylation sites are present in DHBV L,
one in preS and another in the S domain, a PPL-L
derivative in which an Ala for Ser136 substitution abol-
ishes the preS glycosylation site (PPL-LD136, Fig. 1) was
also created to clarify the interpretation of PPL-L glyco-
sylation.
The mutant proteins were expressed in LMH (chicken
hepatoma) cells, with wild-type L as a control. Cells
transfected with the corresponding plasmids were pulse-
labeled with [35S]methionine 1 cysteine and chased
overnight, and comparable amounts of cellular lysates
and culture media were analyzed for the proteins of
interest by immunoprecipitation, SDS–PAGE, and autora-
diography.
Intracellular L was represented by two protein bands
on SDS–PAGE (Fig. 2A, lane L(C)), the slower migrating
band being due to phosphorylation (Grgacic and Ander-
son, 1994, and Fig. 3B, lane L). PPL-LD136 migrated as a
single band, with the same mobility as the nonphosphor-
ylated form of L (Fig. 2A, lanes C). Since the preprolactin
fusion leaves only seven extra amino acid residues at
the N-terminus of L after processing of the signal se-
quence, comigration with the nonphosphorylated form of
L is expected for the full-length, unmodified form of
PPL-LD136. The electrophoretic pattern of PPL-L con-
sisted of an intense band, comigrating with the phos-
phorylated form of L, and a faint band, comigrating with
PPL-LD136 and the nonphosphorylated form of L (Fig. 2A,
lanes C). Further analysis demonstrated that neither the
PPL-L doublet nor the PPL-LD136 band were phosphor-
ylated, and treatment with endoglycosidase H resulted in
the shift of the slower migrating form of PPL-L to the
faster migrating form (data not shown). Therefore it is
safe to relate the bandshift between PPL-L and PPL-
LD136 to N-glycosylation in the preS domain of the
former: PPL-L was nearly 100% glycosylated, and glyco-
sylation was abolished by elimination of the preS N-
glycosylation signal in PPL-LD136. Protease protection
assay confirmed that, as in the case of analogous HBV L
mutants, the preS domains of PPL-L and PPL-LD136
were cotranslationally translocated (E. V. Grgacic, B. Lin,
E. Gazina, and D. A. Anderson, manuscript in prepara-
tion), whereas the preS domain of newly synthesized L
remained in the cytosol, in accordance with the data of
Guo and Pugh (1997).
These results indicated that fusion of the preprolactin
signal sequence to the N-terminus of DHBV L resulted in
cotranslational translocation of the preS domain through
the ER membrane, which was signalled by its N-glyco-
sylation, as in the case of HBV surface proteins.
Strikingly, neither PPL-L nor PPL-LD136 were found to
be secreted, as made clear by their absence in culture
media after pulse–chase (Fig. 2A, lanes M).
Since this result was obtained in LMH cells while
previous results with cotranslationally translocated HBV
L mutants were obtained in COS-7 or 293 cells (Bruss
and Vieluf, 1995; Gallina et al., 1995) there was a possi-
bility that host cell differences might account for the
observed difference in the secretory behavior between
the proteins of the two viruses. We therefore repeated
this experiment in 293 cells. The results were identical to
those obtained in LMH cells (Fig. 2B). The only difference
between the proteins produced in the two cell lines was
that PPL-L and PPL-LD136 synthesized in 293 cells were
partially phosphorylated, as is seen from the appearance
of additional protein bands on SDS–PAGE, and this was
confirmed by in vivo [33P]orthophosphate labeling of the
transfected cells (Fig. 2C). Interestingly, the same phos-
phorylation pattern of PPL-L and PPL-LD136 can be ob-
served in LMH cells incubated in medium supplemented
with 20 nM okadaic acid, whereas wild-type L was phos-
phorylated in both cell lines independently of the pres-
ence of okadaic acid (data not shown). Thus, phosphor-
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ylation of L mutants with cotranslationally translocated
preS required the presence of phosphatase inhibitor in
LMH but not in 293 cells, while wild-type L, which has
cytosolic preS, was phosphorylated independently of the
presence of phosphatase inhibitor in both cell lines. This
result suggests that phosphorylation of the preS domain
occurs on both sides of the ER membrane in the two cell
lines, but that LMH cells contain a protein phosphatase
on the lumenal side of the ER membrane which dephos-
phorylates cotranslationally translocated L mutants.
FIG. 1. Structural features of DHBV L, S, and mutant envelope proteins. The preS domain is shadowed; S domain is white. The start codon for S
protein is shown when present. myr, myristic acid adduct modifying Gly2 of L protein; PPL, preprolactin signal sequence fused N-terminally to Gly2;
*, Ala for Lys substitutions. N-glycosylation sites in positions 134 and 260 are represented as vertical bars: (2), unexploited site, (1/2), site exploited
in a fraction of polypeptides; (1), fully exploited site.
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The results described made a first, relevant point:
cotranslational translocation of preS and the absence of
myristylation do not result in secretion of DHBV L, and
therefore L secretability is not strictly related to these
factors.
Phosphorylation, glycosylation, and export of
truncated proteins L-52, L-95, and L-122
Based on the above results, we asked whether a
defined preS tract was responsible for domain cytosolic
anchoring and/or L intracellular retention. A series of
deletion and point mutants of L were thus studied.
A first panel of L variants included proteins L-52, L-95,
and L-122, in which the first 52, 95, and 122 aa residues
of preS were deleted, respectively (Fig. 1). To analyze the
phosphorylation patterns of mutant proteins we ex-
pressed them in COS-1 cells, with L and S as controls.
COS-1 cells were used for these experiments because
the pCI-neo vector, used for creation of the correspond-
ing plasmids, replicates episomally in COS-1 cells, and
therefore protein production in this cell line is approxi-
mately fivefold higher than in LMH cells, which facilitates
visualization of weakly phosphorylated polypeptides. In
addition, our data demonstrated that the sites of L phos-
phorylation in these two cell lines are identical (E. V.
Grgacic, B. Lin, E. Gazina, and D. A. Anderson, manu-
script in preparation), and therefore it was safe to apply
the results obtained in COS-1 cells to LMH cells.
Proteins were analyzed by metabolic labeling with
[35S]methionine 1 cysteine or 33Pi, immunoprecipitation,
and SDS–PAGE. The electrophoretic patterns of 35S-la-
beled proteins were complex: each mutant was repre-
sented by a number of bands of different intensity (Fig.
3A). Protein bands with molecular masses correspond-
ing to the expected full-length forms are indicated by
arrows. The result of [33P]orthophosphate labeling dem-
onstrated that, in the L-52 triplet, the intermediate protein
band was due to a bandshift caused by phosphorylation:
it was strongly 33P-labeled, whereas very little radioac-
tivity was incorporated into the slowest and fastest mi-
grating forms (Fig. 3B, lane L-52). Phosphorylation of
L-95 did not result in a clear bandshift in this gel (in
contrast to Fig. 3C): the faster migrating band of the
protein was strongly phosphorylated, whereas much
less radioactivity was incorporated in the slower migrat-
ing band (Fig. 3B, lane L-95). Little radioactivity was
incorporated in L-122 (Fig. 3B, lane L-122), consistent
with the identification of serine 118 as a major phosphor-
ylation site in L (E. V. Grgacic, B. Lin, E. Gazina, and D. A.
Anderson, manuscript in preparation; Rothmann, Schno¨l-
zer, Swameye, and Schaller, personal communication;
Borel, Sunyach, Hantz, Trepo, and Kay, personal commu-
nication), which was deleted in L-122.
Thus, phosphorylation analysis demonstrated that the
appearance of the slower bands in L-122 and L-95 dou-
blets, and the slowest band in L-52 triplet was not
caused by phosphorylation. To verify whether they were
generated by preS N-glycosylation we substituted
Ser136 with Ala in the corresponding proteins. The re-
sulting double mutants L-122D136, L-95D136, and
L-52D136 were missing the top bands present in L-122,
L-95, and L-52 when expressed in both LMH and COS-1
cells (Fig. 3C, and data not shown). This result proved
that the top bands of L-52, L-95, and L-122 were due to
glycosylation at the preS site.
The gradual increase in intensity of the top protein
bands from L-52 to L-122 signified that the degree of
preS glycosylation, and hence cotranslational transloca-
FIG. 2. Intracellular retention of PPL-L and PPL-LD136. (A and B) Cells expressing the indicated proteins were pulse-labeled with [35S]methionine 1
cysteine and chased overnight in complete medium. After pulse–chase the proteins were immunoprecipitated from comparable amounts of cellular
lysates (lanes C) and culture media (lanes M) using monoclonal anti-S antibody, resolved by SDS–10% PAGE, blotted to PVDF membrane, and
visualized by autoradiography. (A) LMH cells; (B) 293 cells. (C) Assay for phosphorylation of PPL-L and PPL-LD136 in 293 cells. Separate wells of the
293 cells transfected with the plasmids encoding L, PPL-L, and PPL-LD136 in the experiment descibed in B were pulse-labeled with 33Pi and
harvested for immunoprecipitation. Immunoprecipitated proteins were resolved by SDS–10% PAGE in parallel with 35S-labeled proteins, blotted to
PVDF membrane, and visualized by autoradiography. S, 35S-labeled proteins; P, 33P-labeled proteins. L and PPL-LD136 are partially phosphorylated
in 293 cells. The six top bands in 35S-labeled PPL-L represent (from top to bottom): the first, phosphorylated and glycosylated form; the third
(strongest), glycosylated, nonphosphorylated form comigrating with low amount of phosphorylated, nonglycosylated form; second and fourth,
presumably degradation products of glycosylated forms (as they are absent from PPL-LD136); the fifth (faint), unmodified PPL-L; the sixth, degradation
product which is present also in L and PPL-LD136. Left lanes, marker proteins; molecular masses are in kilodaltons.
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tion, grew with the increase in preS N-terminal deletions:
the shorter the extension of preS which remained in the
mutant, the larger the proportion of polypeptides which
acquired a lumenal topology of this domain. This result
suggested that each of the preS stretches 1–52, 53–95,
95–122, and 123–161 contributed to the cytosolic location
of the preS domain of the full-length L. One could argue
that the lack of glycosylation in a proportion of polypep-
tides of the same protein may be caused by the effect of
protein folding on the efficiency of glycosylation rather
than by the absence of transmembrane translocation,
and therefore the differences in the extent of glycosyla-
tion between the truncation mutants may reflect different
folding of the preS domains of these proteins instead of
their different transmembrane topology. Our arguments
in support of the interpretation of absence of glycosyla-
tion in truncated proteins as the absence of translocation
are as follows. The preS domains of the hepatitis B
viruses lacking N-terminal signal sequences are trans-
located across membranes by downstream signal se-
quence located in the S domain (Eble et al., 1990) and
therefore the preS domain is translocated starting from
the C-terminus. In the studies of the relationship be-
tween folding and glycosylation performed on influenza
virus hemagglutinin it was found that glycosylation took
place rapidly after translocation of the glycosylation sig-
nal, when ;10 additional amino acid residues had
passed through the membrane (Chen et al., 1995). In this
case the folding of all three N-terminally truncated pro-
teins must be identical at the step of glycosylation. In
addition, a cytosolic location of preS in the nonglycosy-
lated form of L-52 is indicated by its phosphorylation in
the absence of okadaic acid in culture medium (the
presence of a band of phosphorylated protein in Figs. 3C
and 4, lanes L-52). Therefore it is reasonable to presume
that nonglycosylated forms of the two other truncation
mutants also contain cytosolic preS.
To analyze secretion, LMH cells transfected with plas-
mids encoding L, LDmyr (nonmyristylated L, Fig. 1), L-52,
L-95, L-122, and S were pulse-labeled with [35S]methi-
onine 1 cysteine and chased overnight, and comparable
amounts of cellular lysates and culture media were sub-
jected to immunoprecipitation. Comparison of patterns of
intra- and extracellular proteins (Fig. 4) demonstrated
that L-52, L-95, and L-122 were partially secreted, all
approximately to the same extent. The extent of their
secretion varied from one experiment to another, but was
always reduced relative to S protein. The presence of
FIG. 3. Phosphorylation and glycosylation of L truncation mutants L-52, L-95, and L-122. COS-1 cells expressing the indicated proteins were
pulse-labeled with [35S]methionine 1 cysteine (A and C) or with 33Pi (B) and harvested for immunoprecipitation with monoclonal anti-S antibody.
Immunoprecipitated proteins were separated by SDS–13% PAGE, blotted to PVDF membrane, and visualized by autoradiography. Migration of marker
proteins is represented on the left (A and B); molecular masses are in kilodaltons. (A) Protein bands with molecular masses corresponding to
full-length proteins are indicated by arrows. (B) Arrows indicate the positions of protein bands visualized by Western blotting performed on the same
membrane using anti-preS guinea pig serum. (C) Assay for glycosylation at the preS site. Mutation of Ser 136 to Ala resulted in the loss of the top
bands in proteins L-52D136, L-95D136, and L-122D136, present in their nonmutated counterparts. Right lane, marker proteins. Note that the top band
of L-52, which is difficult to see in C, is more clearly visible after longer exposure of the autoradiograph (as in A).
FIG. 4. Intra- and extracellular patterns of L, LDmyr, L-52, L-95, L-122,
and S. LMH cells expressing the indicated proteins were pulse–chase
labeled and subsequently processed as described in the legend to Fig.
2, except that the proteins were separated by SDS–13% PAGE. Culture
media (lanes M) or cell lysates (lanes C) are indicated. Positions of L
and S are indicated on the right. Mock, mock-transfected cells.
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mutant proteins in culture medium could not be attrib-
uted to cell death because wild-type L and LDmyr were
not secreted and viability of cells producing L was the
same as that of the cells producing the mutants (these
controls were also made in all the following experi-
ments).
Secretory properties of L-122S2, L-131S2, L-141S2,
and L-151
The L open reading frame contains the start codon for
S protein, resulting in some degree of coexpression of S
from L-encoding plasmids. In the experiments described
above, S coexpression with L and LDmyr was negligibly
low, but it was significantly higher with truncated pro-
teins (Fig. 4, lanes C). This raised the possibility that S
protein, coexpressed with mutants, could partially mask
their retention by transporting them out of cell as com-
ponents of mixed (S plus mutant L) particles.
To examine whether this was actually the case, we
compared transport properties of L-122 and L-122S2, in
which S coexpression was cancelled by the substitution
of the S start codon with a Thr codon in the correspond-
ing plasmid (Fig. 1). The results demonstrated that
L-122S2 was still secreted, but secretion was further
weakened with respect to L-122 (Fig. 5A). This suggested
that S coexpression with L-52, L-95, and L-122 did in-
crease the level of their export.
The level of secretion of L-122S2 was low in compar-
ison with S (Fig. 5B, lanes L-122S2, S). This was com-
patible with the possibility that a discrete L retention
determinant was confined within the 39 amino acid por-
tion of preS which remained in this protein. Attempting to
better define the putative retention signal, three further
truncation mutants were constructed: L-131S2, L-141S2,
and L-151, in which 131, 141, and 151 N-terminal amino
acids of preS were deleted (Fig. 1). To exclude any
contribution of S coexpression with the mutant proteins,
plasmids encoding L-131S2 and L-141S2 contained a
mutation (Thr for Met codon) preventing S coexpression.
Only minute amounts of secreted L-131S2, L-141S2,
and L-151, approximately equal to those of L-122S2,
could be detected in pulse–chase experiments (Fig. 5B).
Secretory properties of L-122DLysS2 and L-122D146-
161S2
The last results further restricted the hypothetical re-
tention signal to the very C-terminus of preS, because
even L-151 which contained only the C-terminal 10 resi-
dues of preS was mostly retained. The striking charac-
teristic of that portion of preS domain is a cluster of four
Lys residues in positions 154, 159, 160, and 161. Clusters
of positively charged amino acid residues are known
determinants of intracellular retention acting on the cy-
tosolic side of the membrane (Nilsson and von Heijne,
1990; Parks and Lamb, 1991; Silverman and Resh, 1992;
Zhou et al., 1994), and these lysine residues have been
demonstrated to play a role in preventing cotranslational
translocation of DHBV preS domains (Swameye and
Schaller, 1997). Although we had demonstrated that
forced cotranslational translocation of preS did not result
in secretion, we could not rule out that the Lys cluster
might serve as a retention signal even when disposed on
the lumenal side of the membrane.
To evaluate these possibilities, we constructed two
L-122S2 derivatives. In one mutant (L-122DLysS2, Fig. 1),
Lys residues in positions 154, 159, 160, and 161 were
substituted with Ala. The second mutant (L-122D146-
161S2, Fig. 1) contained a deletion of 15 amino acids
from the C-terminus of preS, thus ablating the whole
segment of preS present in L-151.
FIG. 5. Secretory properties of L-122S2, L-131S2, L-141S2, and L-151. LMH cells expressing the indicated proteins were pulse–chase labeled and
subsequently processed as described in the legend to Fig. 4. (A) Mock-transfected cells and cells expressing L-122 or L-122 in which the start codon
for S is mutated (L-122S2). (B) Cells expressing L-122S2, L-131S2, L-141S2, L-151 and S. Migration of marker proteins is indicated; molecular masses
are in kilodaltons. Culture media (lanes M) or cell lysates (lanes C) are indicated.
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Substitution of the four Lys residues with Ala caused
nearly complete glycosylation of L-122DLysS2 ex-
pressed in LMH cells: the main part of the protein signal
was converted into a faster migrating band after endogly-
cosydase H treatment, this band being very faint in the
untreated protein (Fig. 6A, lanes L-122DLysS2 and
L-122DLysS2*). L-122D146-161S2 was glycosylated to a
lesser extent although the glycosylated form was still
predominant over nonglycosylated (Fig. 6A, lanes
L-122D146-161S2).
Secretability of both mutants was analyzed in compar-
ison with L-122S2 and S, in pulse–chase experiments
performed in LMH cells as before. Neither L-122DLysS2
nor L-122D146-161S2 showed any increase in the level of
secretion in comparison with L-122S2, as demonstrated
by the minimal amounts of extracellular proteins (Fig.
6B). The fact that L-151 and L-122D146-161S2, which did
not have overlapping preS sequences, were retained
approximately to the same extent (Figs. 5 and 6) sug-
gested that DHBV L retention was not due to any specific
preS sequence. Although we cannot exclude the alter-
native possibility that there are two or more sequences
within preS, each of which could serve as an indepen-
dent retention signal, if that is the case the hypothetical
retention signals must be recognized on both lumenal
and cytosolic sides of the ER or pre-Golgi membrane
since L mutants with both lumenal and cytosolic preS
domains were retained.
S-driven secretion of L and mutant proteins
To exclude the possibility that intracellular retention of
the L mutants might be due to misfolding incompatible
with secretion, caused by mutations or deletions, we
examined whether the most informative mutant proteins
would be secretion-competent in the presence of S pro-
tein. For this purpose LMH cells were cotransfected with
the plasmids encoding wild-type L and the mutants L-151,
L-141S2, L-131S2, L-122S2, L-122D146-161S2, and
L-122DLysS2 together with equimolar amounts of S-en-
coding plasmid. Transfections with S, L, and L-122-
DLysS2 encoding plasmids alone were used as controls.
Coexpression of all examined mutants with S resulted
in their secretion (Figs. 7A and 7B). Thus, the cotransla-
tional translocation of the preS domain, N-glycosylation,
and the mutations introduced in these proteins were not
incompatible with particulate assembly and secretion.
Significantly, wild-type L was also efficiently cosecreted
with S (Fig. 7A, lanes 6).
Both glycosylated and nonglycosylated forms of mu-
tant polypeptides were exported (Figs. 7A and 7B). The
same result was obtained when L-131S2 and L-122D146-
161S2 were coexpressed with S in 293 cells, only in this
cell line secretion of DHBV proteins, including S, was
significantly reduced in comparison with that in LMH
cells (Fig. 7C). These observations, together with the
observation that neither topological form of the same
proteins was efficiently secreted in the absence of S,
lead to the conclusion that the secretory properties of
DHBV surface proteins are independent of the preS
transmembrane topology: rather, a condition for efficient
secretion is a threshold proportion of S polypeptides in
the particle.
Interestingly, the pattern of L-122DLysS2 species co-
secreted with S protein was different from the pattern of
the same protein when secreted alone. The majority of
L-122DLysS2 polypeptides secreted in the presence of S
appeared to have undergone oligosaccharide trimming
in the Golgi compartment, which was signalled by the
increase of the molecular mass of the secreted protein in
comparison with its intracellular form (Fig. 7B, lanes 3M
and 3C). Glycans remained without Golgi processing in
only a minor part of the secreted polypeptides. The same
situation was observed with L-122D146-161S2 cose-
creted with S (Fig. 7B, lanes 2M and 2C). However, when
L-122DLysS2 was expressed without S, the major part of
the secreted polypeptides did not undergo Golgi oligo-
saccharide trimming (Fig. 7B, lanes 6M and 6C). The
presence of two forms of the glycosylated polypeptides
in culture media might be due to the existence of two
alternative pathways of secretion for DHBV surface pro-
teins; however, further experiments are needed to exam-
ine this hypothesis.
Secretory behavior of DHBV L and HBV L in the
presence of S
Wild-type DHBV L appeared to be readily cosecreted
with S (Fig. 7A, lanes 6). This observation was contrary to
the previous data obtained for the HBV proteins (Chisari
FIG. 6. Assay for the role of the C-terminal part of preS in L retention.
(A) Immunoprecipitated proteins from 35S-pulse-labeled LMH cells ex-
pressing the indicated proteins were treated (1) or mock-treated (2)
with endoglycosydase H before SDS–PAGE analysis. L-122DLysS2* is
a longer autoradiography of L-122DLysS2. (B) LMH cells expressing
the indicated proteins were pulse–chase labeled and subsequently
processed as described in the legend to Fig. 4. Migration of marker
proteins is represented in the middle; molecular masses are in kilo-
daltons. Culture media (lanes M) or cell lysates (lanes C) are indicated.
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et al., 1986; Ou and Rutter, 1987; Persing et al., 1986;
Standring et al., 1986). Therefore, we compared the se-
cretory properties of coexpressed wild-type L and S
between DHBV and HBV.
LMH and 293 cells were cotransfected with plasmids
encoding L and S in various ratios, pulse–chase 35S-la-
beled, and the proteins were immunoprecipitated from
comparable amounts of cell lysates and culture media,
separated by SDS–PAGE, and transferred to PVDF mem-
brane as before. Relative amounts of L and S were quan-
titated using FLA-2000 PhosphorImager (Fuji) and/or Flu-
or-S MultiImager (Bio-Rad) for densitometry of autoradio-
graphs of the membranes. Relative numbers of Met and
Cys residues in each protein were taken into account in
calculation of the molar ratios between the proteins.
The dependence of DHBV and HBV protein secretion
efficiency on the cell line was analyzed by comparison of
the ratios of extra- to intracellular S in LMH and 293 cells
producing S alone. The data obtained demonstrated that
levels of DHBV S secretion in LMH cells and HBV S
secretion in both LMH and 293 cells were approximately
the same, with intra- to extracellular protein ratios vary-
ing from 1:1 to 3.5:1 in different experiments, whereas
DHBV S secretion from 293 cells was five- to seven-fold
lower (data not shown).
A major difference in secretion of the L proteins of the
two viruses was revealed by comparing the relative
amounts of S and L proteins inside cells and in culture
media. DHBV S to L ratios inside cells and in culture
media were similar in both LMH and 293 cells over a
wide range of total S:L ratios (Table 1, Figs. 8A and 8B,
lanes 1 and 2). In contrast, the extracellular ratio of HBV
proteins was shifted toward a lower L content in com-
parison with the intracellular ratio: L content in secreted
HBV protein particles was 8.9-fold lower than its propor-
tion inside LMH cells (Table 1, Fig. 8A, lanes 3 and 4), and
2.5-fold lower than inside 293 cells (Table 1, Fig. 8B,
lanes 3 and 4).
FIG. 7. S-driven secretion of DHBV L and L mutants. LMH (A and B) or 293 (C) cells in six-well plates were cotransfected with a total amount of
10 mg per well of plasmids encoding the indicated proteins in the indicated ratios. In cases when the cells were transfected with one plasmid only,
the amount of plasmid per well is indicated. Transfected cells were pulse–chase labeled and subsequently processed as described in the legend
to Fig. 4. (A) Arrows indicate the positions of protein bands representing the truncation mutants and L. (B) Left lane, marker proteins; molecular
masses are in kilodaltons. (C) Right lane, marker proteins; molecular masses are as in B. Culture media (lanes M) or cell lysates (lanes C) are
indicated.
A B C
1. S, 5 mg 1. L-122S2:S 5 1:1 1. L-131S2:S 5 1:1
2. L-151:S 5 1:1 2. L-122D146-161S2:S 5 1:1 2. L-122D146-161S2:S 5 1:1
3. L-141S2:S 5 1:1 3. L-122DLysS2: S 5 1:1 3. S, 10 mg
4. L-131S2:S 5 1:1 4. S, 5 mg
5. L-122S2:S 5 1:1 5. S, 10 mg
6. L:S 5 1:1 6. L-122DLysS2, 10 mg
7. L, 10 mg
8. Mock transfection
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These results demonstrated that despite some differ-
ences in secretory behavior of the viral surface proteins
related to the host cells and experimental variation, HBV
L was always partially excluded from secreted protein
particles, whereas no such selection could be detected
for DHBV L.
DISCUSSION
The N-terminal preS domains of both HBV L and DHBV
L initially remain in the cytosol and only posttranslation-
ally a fraction of polypeptides reorient their preS do-
mains to the lumenal side of the membrane (Bruss et al.,
1994; Guo and Pugh, 1997; Ostapchuk et al., 1994;
Prange and Streeck, 1995). Previously published data
demonstrate that, along with myristylation, this cytosolic
disposition of the preS domain plays a key role in the
intracellular retention of HBV surface proteins: only those
N-terminally truncated mutants of HBV L, which can
efficiently translocate their preS domains through the ER
membrane, undergo secretion in the absence of S, and
forced cotranslational translocation of preS results in
secretion of the full-length, nonmyristylated L (Bruss and
Vieluf, 1995; Gallina et al., 1995). In addition, only that
proportion of polypeptides of M protein and secretable L
mutant proteins which have cotranslationally translo-
cated preS domains become efficiently secreted (Gallina
et al., 1995). In contrast, our data suggest that the
secretory properties of DHBV surface proteins are inde-
pendent of the transmembrane topology of their preS
domains: even relatively short preS extensions on the
N-terminus of S, regardless of whether they are translo-
cated across the ER membrane, cause significant reten-
tion of the corresponding proteins expressed in the ab-
sence of S. Furthermore, retention of both topological
forms is relieved by coexpression with S.
TABLE 1











LMH 1.4 1.7 1.4 nd
2.4 1.0 1.9c 7.8 ;8.9
3.6 1.0 2.5c nd




293 2.1 0.7 1.7 4.4
3.9 1.4 ;1.0 2.6 1.6 ;2.5
6.3 1.3 2.8 1.9
7.4 0.8 3.0 2.2
Note. nd, L not detectable in culture medium.
a Molar ratio between total amounts of S and L in culture medium
and cell lysate.
b The proportion between molar ratios S:L in culture medium and cell
lysate.
c Note that the well-established relationship between increases in
intracellular HBV S:L ratio and increases in L export is not apparent
from these experiments due to a combination of very low levels of L
secretion from LMH cells and some variation in the level of total protein
production between the experiments, which resulted in L being unde-
tectable in culture medium in one case with a higher total S:L ratio (2.5)
than in another (1.9) in which L was detectable.
FIG. 8. Secretory behavior of DHBV L and HBV L in the presence of S. LMH (A) or 293 (B) cells in six-well plates were cotransfected with a total
amount of 10 mg per well of plasmids, which resulted in production of the indicated proteins in the indicated molar ratios. Transfected cells were
pulse–chase labeled and subsequently processed as described in the legend to Fig. 4, except that HBV proteins were immunoprecipitated with
anti-HBs antibody (DAKO). Positions of DHBV L and S are indicated on the left side, positions of HBV L and S (glycosylated and nonglycosylated forms)
on the right.
A B
1. DHBV S:L 5 3.6 1. DHBV S:L 5 2.1
2. DHBV S:L 5 8.2 2. DHBV S:L 5 7.4
3. HBV S:L 5 2.5 3. HBV S:L 5 1.7
4. HBV S:L 5 6.4 4. HBV S:L 5 2.8
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Another major difference between HBV and DHBV
surface proteins emerges from our work, in that DHBV L
is efficiently incorporated into L1S mixed particles which
undergo secretion, whereas HBV L is partially excluded
from secreted particles when coexpressed with S. The
exclusion of HBV L from secreted particles is evident
also from examination of previously published experi-
ments performed in HepG2, COS-7, and Xenopus oocytes
(Bruss and Ganem, 1991; Bruss and Thomssen, 1994;
Standring et al., 1986).
The exclusion of polypeptides with cytosolically lo-
cated preS from secreted particles formed by HBV M and
secretable L mutants (Gallina et al., 1995) suggests that
it is the cytosolic location of preS which hampers the
incorporation of HBV L into subviral particles. Probably,
in the case of DHBV, it is the absence of such topological
selection which allows L to be efficiently coassembled
with S, the secretability of resulting particles being de-
pendent on the proportion of S polypeptides in the par-
ticle.
It appears, therefore, that HBV has a mechanism pro-
viding L retention even in coexpression with an excess of
S, which we will term dominant retention, by means of
selection of the polypeptides with cytosolic preS from
assembling subviral particles. Our results clearly dem-
onstrate that such dominant retention of L is absent in
DHBV. The biological significance of this major differ-
ence may be appreciated by considering the different
patterns of protein expression by the two viruses in the
course of natural infections. HBV produces S and M
proteins in nearly 100-fold excess over L: only one L
molecule for 100 protein subunits is present in spherical
subviral particles, which represent 98–99% (wt/wt) of the
HBV surface protein in the blood of infected persons
(Heermann and Gerlich, 1991; Heermann et al., 1984).
However, only a four-fold excess of S and M over L is
incorporated in virions (Heermann et al., 1984). The ex-
clusion of HBV L protein from spherical subviral particles
and its retention may thus be a mechanism providing
accumulation of this protein necessary for the formation
of virions. In the case of DHBV, L and S are produced in
the ratio 1:4 (Schlicht et al., 1987), therefore no specific
mechanism is needed to prevent L incorporation in sub-
viral particles in order to retain enough L for virion for-
mation.
The ability of HBV L to form intracellular spherical
particles in the absence of S, such particles being bound
in the lumen of the pre-Golgi compartment by associa-
tion with calnexin (Xu et al., 1997), has recently been
proposed as an alternative mechanism for HBV L reten-
tion. However, it is not possible at this time to distinguish
between the mechanism of retention and the fate of L
which has been retained. It appears unlikely that the
calnexin-associated L particles could fulfil a function of
providing L for virion assembly. We argue instead that
during coexpression with S and M, HBV L is most likely
excluded from spherical subviral particles before bud-
ding, during assembly on the pre-Golgi membrane. Ac-
cumulation of this excluded L on the membrane may
sometimes result in the formation of L-enriched spheri-
cal particles and their budding into the lumen where they
are retained (Xu et al., 1997), but in natural infection it will
mostly result in formation and secretion of alternative
L-enriched particles—filaments and virions. Formation
and secretion of these particles is much more cell type-
dependent than that of spherical particles (Heermann
and Gerlich, 1991) and therefore may require participa-
tion of cellular factors which are not engaged in secre-
tion of spherical subviral particles.
MATERIALS AND METHODS
Plasmids
A construct encoding wild-type DHBV L (pCI L) was
created by inserting a SacI–XbaI fragment of the plasmid
pUC119.CPS (Lenhoff and Summers, 1994), which con-
tains a segment of DHBV DNA (Mandart et al., 1984)
beginning at nucleotide (nt) 719 and ending at the XbaI
site at nt position 2662, into the XhoI–XbaI-cut multiclon-
ing region of the vector pCI-neo (Promega, Madison, WI).
A plasmid encoding S (pCI S) was made by deleting the
fragment spanning NheI (in the multicloning site of the
vector) to XhoI (nt position 1212 in DHBV DNA) from pCI
L. Plasmid pCI LDmyr was constructed by inserting a
DraI–XbaI fragment of DHBV DNA (nt 742 to 2662) cut
from the plasmid 805C (Summers et al., 1991), into pCI-
neo cut with SmaI1XbaI.
Deletion of the fragment NheI–AspI (nt position 905 in
DHBV DNA) from pCI L generated the truncation mutant
pCI L-52. Other deletion mutants were created using
synthetic oligonucleotide linkers, described in Table 2.
pCI L-95 was created by insertion of linker -95 in NheI–
XmnI (nt position 1096 of DHBV DNA)-cut pCI L. To
construct pCI L-122, linker -122 was inserted in NheI–
XhoI-cut pCI L. pCI L-122S2 was constructed by substi-
tution of the XhoI–EcoRV fragment (nt 1212 to 2652 of
DHBV DNA) of pCI L-122 with the same restriction frag-
ment of the plasmid 1285C (Summers et al., 1991) in
which the start codon for S is mutated. Substitution of the
NheI–XhoI fragment of pCI L-122S2 with linker -131 re-
sulted in pCI L-131S2. pCI L-141S2 was created by sub-
stitution of fragment NheI–MspA1 I (nt position 1245 of
DHBV DNA) of pCI L-122S2 with linker -141. The fragment
NheI–KpnI (nt position 1294 of DHBV DNA) of pCI
L-122S2 was substituted with linker -151 to create pCI
L-151.





GGCACAGCAGCAGGTTTGACACCAGC-39, which are com-
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plementary at their 39-terminal 20 bases, were diluted to 50
mM in a 100 ml reaction volume, in the presence of 200
mM dNTPs and 10 units of Pfu polymerase (Stratagene,
La Jolla, CA), in the polymerase buffer conditions sug-
gested by the manufacturer. The mixture was subjected
to 10 cycles of denaturation, annealing, and extension
(94°C/30 s, 60°C/30 s, 74°C/30 s). The resulting 138-bp
dsDNA fragment, which encodes human preprolactin
signal sequence fused to DHBV preS codons 2–12, was
double digested with NheI and AatII (underlined, cutting
upstream from the preprolactin ATG (bold) and at DHBV
preS codon 10, respectively) and cloned into plasmid pCI
L between the same sites, to replace the natural preS 59
end. The synthetic insert was sequenced to rule out
polymerase misincorporations.
Plasmids pCI L-122D136, pCI L-95D136, pCI L-52D136,
and pCI PPL-LD136 were created by substitution of linker
D136 for the XmaI–XhoI fragments (nt 1176 to 1212 of
DHBV DNA) of pCI L-122, pCI L-95, pCI L-52, and pCI
PPL-L, respectively. pCI L-122DLysS2 was constructed
by substitution of the MspA1 I–KpnI fragment (nt 1245 to
1294 of DHBV DNA) of L-122 with linker DLys. pCI
L-122D146-161S2 was created by substituting the XhoI–
KpnI fragment (nt 1212 to 1294 of DHBV DNA) of pCI
L-122 with linker D146.
Plasmids encoding HBV L and S proteins are de-
scribed elsewhere (Gallina et al., 1992).
Cells and transfections
LMH cells were maintained in Dulbecco’s modified
Eagle’s medium (DMEM)-F12 supplemented with 10%
fetal bovine serum (FBS). COS-1 and 293 cells were
maintained in DMEM, 10% FBS. Transfections were car-
ried out by the calcium phosphate method (Gorman,
1985), with 10 mg of DNA per well (unless indicated
otherwise) in six-well multiplates (Greiner, Fricken-
hausen, Germany). For cotransfections the plasmids
were mixed in the indicated molar ratios so that the total
amount of DNA was 10 mg.
In vivo 35S-labeling
Two days posttransfection, cells were labeled with 150
mCi per well of [35S]methionine 1 cysteine (TransLabel,
ICN), in methionine- and cysteine-free medium (ICN,
Costa Mesa, CA), for 3 h. Cells were then either har-
vested or chased for a further 20 h in 1.5 ml of complete
medium.
After either pulse or pulse–chase labeling, cells were
lysed in 500 ml of ice-cold lysis buffer (10 mM Tris–HCl,
150 mM NaCl, 1 mM EDTA, 1% Nonidet P-40, 0.5% so-
dium deoxycholate, 1 mM PMSF, pH 7.5). Cell lysates
were spun for 5 min in an Eppendorf microfuge at 4°C,
and 400 ml of supernatants was transferred to fresh
tubes, and equal volumes of RIPA buffer (0.1% SDS in
lysis buffer) were added for subsequent immunoprecipi-
tation. Precleared culture media (1.2 ml) were subjected
to immunoprecipitation after addition of 133 ml of 10%
Nonidet P-40.
Immunoprecipitations were performed by incubating
each sample at 4°C with 20 ml of monoclonal anti-S
antibody 7C.12 (Pugh et al., 1995) for 3 h, followed by
incubation with 30 ml of 10% protein A–Sepharose slurry
(Pharmacia, Uppsala, Sweden) for 1.5 h. Sepharose
beads were then washed, boiled in SDS–PAGE loading
buffer, and spun, and the supernatants were loaded onto
SDS–polyacrylamide gels. After electrophoresis, pro-
teins were transferred to polyvinyl difluoride membrane
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Endoglycosydase H treatments were done as de-
scribed previously (Gallina et al., 1995).
In vivo 33Pi-labeling
Two days posttransfection, cells were labeled for 6 h
with 500 mCi per well of 33Pi (Amersham, Buckingham-
shire, UK) in phosphate-free medium (ICN, Costa Mesa,
CA) supplemented with 20 nM okadaic acid (Calbio-
chem, La Jolla, CA). Cells were then harvested in 500 ml
of NT (10 mM Tris, 100 mM NaCl, 50 mM NaF, 1 mM
PMSF, pH 7.5) and lysed by freeze–thawing. Membrane
fractions were isolated as described previously for pri-
mary duck hepatocytes (Grgacic and Anderson, 1994)
except that the membrane pellet was resuspended in
250 ml NT, 1% Nonidet P-40. RIPA buffer (250 ml) was
added to membrane fractions and proteins were immu-
noprecipitated and analyzed by SDS–PAGE and autora-
diography as described above except that samples were
precleared by incubation with 30 ml of protein A–Sepha-
rose before incubation with antibody.
To assign radioactive bands to corresponding protein
bands, membranes were immunostained after autora-
diography using guinea pig anti-preS serum and en-
hanced chemiluminescence as previously described (Gr-
gacic and Anderson, 1994).
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